Patents by Inventor Steven P. Braithwaite

Steven P. Braithwaite has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors
    Publication number: 20230346764
    Abstract: Methods of treating symptoms of skin disorders with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in pruritis, xerosis, or other skin disorder-affected function. Skin disorders upon which the methods of the invention can improve symptoms and causes of the disorders include eczema, bullous pemphigoid, atopic dermatitis, and psoriasis.
    Type: Application
    Filed: March 9, 2023
    Publication date: November 2, 2023
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Arnaud E.J. Teichert
  • Blood Plasma Fractions for Improvement of Myelination
    Publication number: 20230069856
    Abstract: Methods and compositions for restoring myelin levels in conditions associated with myelin degeneration, for example, an aging and aging-related neurodegenerative and/or neuroinflammatory disease or a myelopathy associated with postoperative recovery. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in restoring myelin levels and/or improving nerve conductance.
    Type: Application
    Filed: November 11, 2022
    Publication date: March 9, 2023
    Inventors: David Bell, Steven P. Braithwaite, Vu Dang, Ian Gallager, Joe McCracken, S. Sakura Minami, Karoly Nikolich, Jung Hyung Sin
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 11413308
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: August 16, 2022
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
    Patent number: 11382907
    Abstract: Methods of improving neurodegenerative disease with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in cognition, motor, or other neurodegenerative-affected function. Cognitive and motor diseases upon which the methods of the invention can improve cognition include Alzheimer's disease, Parkinson's disease, frontotemporal dementia, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, glaucoma, myotonic dystrophy, vascular dementia, progressive supranuclear palsy.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: July 12, 2022
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Karoly Nikolich
  • Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders
    Publication number: 20220152161
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 19, 2022
    Inventors: David Bell, Ian Gallager, Steven P. Braithwaite, S. Sakura Minami, Vu Dang, Joe McCracken, Karoly Nikolich
  • Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
    Publication number: 20210315932
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Application
    Filed: May 18, 2021
    Publication date: October 14, 2021
    Inventors: Steven P. Braithwaite, Meghan Kerrisk Campbell, Eva Czirr, Ian Gallager, Nina Huber, Sam Jackson, S. Sakura Minami
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 11040068
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: June 22, 2021
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Meghan Kerrisk Campbell, Eva Czirr, Ian Gallager, Nina Huber, Sam Jackson, S. Sakura Minami
  • Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
    Publication number: 20210113612
    Abstract: The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 22, 2021
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Joseph McCracken
  • Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
    Publication number: 20210060063
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Application
    Filed: November 13, 2020
    Publication date: March 4, 2021
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Blood plasma and plasma fractions as therapy for tumor growth and progression
    Patent number: 10905717
    Abstract: The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: February 2, 2021
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Joseph McCracken
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 10874692
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: December 29, 2020
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors
    Publication number: 20200054622
    Abstract: Methods of improving neurodegenerative disease with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in cognition, motor, or other neurodegenerative-affected function. Cognitive and motor diseases upon which the methods of the invention can improve cognition include Alzheimer's disease, Parkinson's disease, frontotemporal dementia, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, glaucoma, myotonic dystrophy, vascular dementia, progressive supranuclear palsy.
    Type: Application
    Filed: September 25, 2019
    Publication date: February 20, 2020
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Karoly Nikolich, Sanket V. Rege, Arnaud E.J. Teichert
  • Blood plasma fractions as a treatment for aging-associated cognitive disorders
    Patent number: 10525107
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: January 7, 2020
    Assignee: Alkahest, Inc.
    Inventors: David Bell, Ian Gallager, Steven P. Braithwaite, S. Sakura Minami, Vu Dang, Joe McCracken, Karoly Nikolich
  • Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
    Publication number: 20190328782
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 31, 2019
    Inventors: Steven P. Braithwaite, Meghan Kerrisk Campbell, Eva Czirr, Ian Gallager, Nina Huber, Sam Jackson, S. Sakura Minami
  • Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders
    Publication number: 20190321449
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.
    Type: Application
    Filed: June 28, 2019
    Publication date: October 24, 2019
    Inventors: David Bell, Ian Gallager, Steven P. Braithwaite, S. Sakura Minami, Vu Dang, Joe McCracken, Karoly Nikolich
  • Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
    Publication number: 20190282617
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Application
    Filed: June 5, 2019
    Publication date: September 19, 2019
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 10357513
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: July 23, 2019
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
    Publication number: 20190167719
    Abstract: The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.
    Type: Application
    Filed: February 12, 2019
    Publication date: June 6, 2019
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Joseph McCracken
  • Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR-Inhibitors
    Publication number: 20190111042
    Abstract: Methods of treating symptoms of skin disorders with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in pruritis, xerosis, or other skin disorder-affected function. Skin disorders upon which the methods of the invention can improve symptoms and causes of the disorders include eczema, bullous pemphigoid, atopic dermatitis, and psoriasis.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 18, 2019
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Arnaud E.J. Teichert
  • Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors
    Publication number: 20190105314
    Abstract: Methods of improving neurodegenerative disease with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in cognition, motor, or other neurodegenerative-affected function. Cognitive and motor diseases upon which the methods of the invention can improve cognition include Alzheimer's disease, Parkinson's disease, frontotemporal dementia, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, glaucoma, myotonic dystrophy, vascular dementia, progressive supranuclear palsy.
    Type: Application
    Filed: April 4, 2018
    Publication date: April 11, 2019
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Karoly Nikolich